NDC 50742-299

FROVATRIPTAN

Frovatriptan Succinate

FROVATRIPTAN is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Ingenus Pharmaceuticals, Llc. The primary component is Frovatriptan Succinate.

Product ID50742-299_0213d55b-636b-486d-b172-53b445325be6
NDC50742-299
Product TypeHuman Prescription Drug
Proprietary NameFROVATRIPTAN
Generic NameFrovatriptan Succinate
Dosage FormTablet, Film Coated
Route of AdministrationORAL
Marketing Start Date2022-07-22
Marketing CategoryANDA /
Application NumberANDA213891
Labeler NameIngenus Pharmaceuticals, LLC
Substance NameFROVATRIPTAN SUCCINATE
Active Ingredient Strength3 mg/1
Pharm ClassesSerotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 50742-299-09

1 BLISTER PACK in 1 CARTON (50742-299-09) > 9 TABLET, FILM COATED in 1 BLISTER PACK
Marketing Start Date2022-07-22
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "FROVATRIPTAN" or generic name "Frovatriptan Succinate"

NDCBrand NameGeneric Name
0378-3140Frovatriptanfrovatriptan
50742-299FROVATRIPTANfrovatriptan succinate
69238-1539FrovatriptanFrovatriptan succinate
50436-0026FROVAfrovatriptan succinate
63481-025FROVAfrovatriptan succinate
0603-3718Frovatriptan Succinatefrovatriptan succinate
68462-694frovatriptan succinatefrovatriptan succinate

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.